Wave Life Sciences
91 hedge funds and large institutions have $306M invested in Wave Life Sciences in 2020 Q2 according to their latest regulatory filings, with 22 funds opening new positions, 28 increasing their positions, 24 reducing their positions, and 9 closing their positions.
144% more first-time investments, than exits
New positions opened: 22 | Existing positions closed: 9
42% more call options, than puts
Call options by funds: $1.71M | Put options by funds: $1.21M
17% more funds holding
Funds holding: 78 → 91 (+13)
17% more repeat investments, than reductions
Existing positions increased: 28 | Existing positions reduced: 24
9% more capital invested
Capital invested by funds: $282M → $306M (+$24.2M)
4.8% less ownership
Funds ownership: 87.15% → 82.35% (-4.8%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
+$7.28M |
| 2 |
GTC
Ghost Tree Capital
New York
|
+$5.03M |
| 3 |
D.E. Shaw & Co
New York
|
+$4.99M |
| 4 |
BlackRock
New York
|
+$4.6M |
| 5 |
Morgan Stanley
New York
|
+$4.36M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RG
Redmile Group
San Francisco,
California
|
-$23.6M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
-$18.6M |
| 3 |
RI
RTW Investments
New York
|
-$9.4M |
| 4 |
SIM
Spark Investment Management
New York
|
-$754K |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$622K |
WVE Hedge Fund Activity: Q2 2020 in Review
91 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Wave Life Sciences (WVE) for Q2 2020, worth a combined $306M — up 8.6% from $282M a quarter earlier.
Buyers outnumbered sellers: 22 funds opened new WVE positions and 9 closed out — a net gain of 13 holders — while 28 added to existing stakes and 24 trimmed.
The largest buyer was Nantahala Capital Management, adding an estimated $7.28M. The largest seller was Redmile Group, cutting an estimated $23.6M.
- 91 institutional investors held Wave Life Sciences (WVE) as of Q2 2020, up from 78 in Q1 2020.
- Funds reported $306M of Wave Life Sciences stock for Q2 2020, up 8.6% quarter-over-quarter.
- 22 funds opened new Wave Life Sciences positions in Q2 2020 and 9 closed out, a net change of +13 holders.
- The largest Wave Life Sciences buyer in Q2 2020 was Nantahala Capital Management, an estimated $7.28M added.
- The largest Wave Life Sciences seller in Q2 2020 was Redmile Group, an estimated $23.6M sold.
Based on aggregated 13F filings for Q2 2020.